Author:
Mizutani Hideki,Hiraku Yusuke,Tada-Oikawa Saeko,Murata Mariko,Ikemura Kenji,Iwamoto Takuya,Kagawa Yoshiyuki,Okuda Masahiro,Kawanishi Shosuke
Subject
Cancer Research,Oncology,General Medicine
Reference34 articles.
1. FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No 968. I, Taxonomy, fermentation, isolation, physico-chemical and biological properties, and antitumor activity;Ueda;J Antibiot (Tokyo),1994
2. FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. III. Antitumor activities on experimental tumors in mice;Ueda;J Antibiot (Tokyo),1994
3. Clinical and molecular responses in lung cancer patients receiving Romidepsin;Schrump;Clin Cancer Res,2008
4. Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma;Piekarz;J Clin Oncol,2009
5. The histone deacetylase inhibitor FR901228 induces caspase-dependent apoptosis via the mitochondrial pathway in small cell lung cancer cells;Doi;Mol Cancer Ther,2004
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献